Schedule 13D ownership disclosure

POINT BIOPHARMA GLOBAL INC

Security class unavailable · CUSIP: 730541109

Event date: 2023-10-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-106344
Form type
SC 13D/A
Filer
POINT Biopharma Global Inc.
CIK
CIK 1811764
Filed
Oct 03, 2023
Reporting period
Oct 02, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub